Center for Disease Analysis Foundation Announces Receipt of an $8 Million Grant from Gilead Sciences to Relink Hepatitis B and C Patients to Care in the United States

LAFAYETTE, Colo., July 20, 2023 (GLOBE NEWSWIRE) -- The Center for Disease Analysis Foundation (CDA Foundation) announced today that it received an $8 million grant from Gilead Sciences (Nasdaq: GILD) as part of Gilead’s Relink grant program. CDA Foundation will disperse the grant to qualifying tax-exempt organizations to contact diagnosed but untreated patients with hepatitis C virus (HCV) or hepatitis B virus (HBV) infection to bring them back into care.

Despite the availability of existing treatment and vaccination options; in the United States an estimated 2.4 million people are living with HCV, and 850,000 are estimated to be living with HBV, according to the U.S. Department of Health and Human Services. Both viruses are responsible for increasing rates of cirrhosis, liver cancer, liver failure and premature deaths. According to CDA Foundation’s research, the risk of developing cancer for someone infected with HCV or HBV infection is the same as someone who smokes one pack of cigarettes per day. HCV and HBV are associated not only with liver cancer but also increased risk of lymphoma, diabetes, insulin resistance, renal disease, fatigue, cognitive impairment, depression, impaired quality of life, arthritis, fibromyalgia and cardiovascular disorders.

Recognizing the growing continued risk of viral hepatitis, the World Health Organization set a global target to eliminate viral hepatitis as a major public health threat by 2030. Despite the availability of oral drugs with high cure rates for HCV and effective therapies for HBV, this goal has been impeded because many patients diagnosed with viral hepatitis are unaware of their infection, do not seek follow-up care, or delay treatment. According to a recent study by U.S. CDC, less than 30% of all Medicaid, Medicare, and private insurance recipients initiate treatment within one year of being diagnosed in the U.S. The Relink grant program aims to identify and work to bridge the gaps that remain in linking patients back to necessary care and treatment.

Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19 and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.

“Hepatitis B and C viruses are highly cancer causing. The Gilead Relink grant is an important example of how public and private partnership can shape viral hepatitis elimination programs that will help the United States achieve WHO targets by 2030,” said Homie Razavi, Founder and Managing Director, CDA Foundation. “In order to improve viral hepatitis patient outcomes in the United States, we must ensure that individuals not only have access to but are also guided toward affordable and effective prevention, care and treatment services.”

“Gilead has been committed to improving the lives of people living with liver disease for more than two decades, and we are thrilled to expand our support to healthcare organizations through the new Gilead Relink grant program,” said Macky Natha, Vice President, Medical Affairs, Gilead Sciences. “As we work toward eliminating viral hepatitis as a public health threat by 2030, we must address barriers to treatment by relinking the people who have been lost in the process, and that’s what the CDA Foundation and other impactful organizations will help accomplish through this program.”

For more information, please visit https://cdafound.org/relink or contact CDA Foundation at relink@cdafound.org.

About Center for Disease Analysis Foundations

CDA Foundation is a non-profit organization that seeks to help eliminate HBV and HCV globally by 2030 by providing countries across the world with verified epidemiological data, disease burden and economic impact modeling, smart intervention strategies, access to affordable diagnostics and treatments, innovative financing, and knowledge-sharing partnerships to eliminate these deadly infections. It works with more than 110 countries globally and 26 US states on their viral hepatitis elimination programs. It is headquartered in Lafayette, Colorado.

Contact: Homie Razavi
  hrazavi@cdafound.org


Center for Disease Analysis Foundation Announces Receipt of an $8 Million Grant from Gilead Sciences to Relink Hepatitis B and C Patients to Care in the United States

TIN LIÊN QUAN

Cowlitz Tribal Foundation Celebrates 2022 Grant Recipients

The Cowlitz Tribal Foundation’s philanthropic efforts topped $8 million in 2022, with grants distributed to 110 nonprofits in Clark County and throughout...

Terracon Foundation Awards Over $90,000 in Grants

Grants and scholarships made to universities and organizations throughout U.S....

Seattle Humane to Address Lack of Affordable Veterinary

Bellevue, Washington, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Nearly 50 million pets in the U.S. cannot access even the most basic veterinary care. Due to cost...

DentaQuest Opens Nominations for 2023 Health Equity Heroes

The awards recognize individuals and organizations working toward equitable access to oral care and optimal health outcomes...

THỦ THUẬT HAY

Hướng dẫn thêm Column vào menu Start của Windows 10

Theo mặc định, Windows 10 hiển thị ba cột (Column) trong menu Start. Tuy nhiên, có một cột thứ tư ẩn có thể hiển thị cho bạn nhiều ứng dụng và thông tin nhanh hơn khi bạn nhấp vào nút Windows.

Cách sửa lỗi không gõ được Tiếng Việt cho thư mục Windows

Để dễ dàng quản lý các thư mục, chúng ta thường đặt tên Tiếng Viêt cho từng thư mục đó. Tuy nhiênn vì một số lỗi mà người dùng không thể gõ được Tiếng Việt cho thư mục Windows

Phát hiện lỗ hổng bảo mật nguy hiểm hơn cả Heartbleed

Shellshock - một lỗ hổng bảo mật nghiêm trọng có khả năng ảnh hưởng đến hàng trăm triệu máy tính, máy chủ và các thiết bị đã được tìm thấy.

3 cách giúp kiểm tra pin iphone bị chai

Cách làm này sẽ hơi mất thời gian một chút, cụ thể là có thể lên tới 2 ngày chờ đợi từ sever của Apple để phản hồi. Nhưng bù lại, bạn sẽ có được một kết quả chuẩn xác về tình trạng pin của thiết bị.

ACMarket - Dễ dàng tải miễn phí ứng dụng bản quyền và các bản mod dành cho smartphone Android

Đầu tiên, bạn cần tải về và cài đặt ACMarket trên thiết bị (lưu ý cần tin cậy một số yêu cầu truy cập trên thiết bị và nguồn không xác định do cài đặt bằng gói APK nhé)

ĐÁNH GIÁ NHANH

Đánh giá Samsung Chromebook Pro. Bạn có nên bỏ tiền mua ?

Samsung Galaxy Chromebook được tung ra thị trường với 2 màu rất nổi bật và đẹp mắt đó là màu Mercury Grey (xám) và màu Fiesta RED (đỏ). Vì là sản phẩm thuộc phân khúc cao cấp đồng thời tích hợp nhiều tính năng hiện đại

Trên tay Xiaomi 11 Lite 5G NE – Smartphone mỏng, nhẹ, hiệu năng tốt

Xiaomi 11 Lite 5G NE đã chính thức được trình làng và để lại những ấn tượng tốt với người dùng. Khi cầm trên tay Xiaomi 11 Lite 5G NE, máy rất nhẹ và mỏng. Không những vậy hiệu năng của máy còn khá ổn áp. Ngoài những